Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Methotrexate Significantly Reduced Knee OA Pain

Publish date:: June 10, 2019

Key clinical point: Oral methotrexate achieved significant reductions in knee osteoarthritis pain, stiffness, and functional impairment.

Major finding: The standard effect size for methotrexate in terms of pain reduction was 0.36, considered to be moderate.

Study details: This multicenter, randomized, double-blind, placebo-controlled clinical trial included 134 patients evaluated at 6 months.

Disclosures: The presenter reported having no financial conflicts regarding the PROMOTE trial, which was funded by the U.K. National Institute for Health Research and Versus Arthritis.

Citation:

Conaghan PG et al. OARSI 2019, Abstract 86.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Pain

Real acupuncture beat sham for osteoarthritis knee pain,

Appendix may be common site of endometriosis,

NSAID continuation linked to less knee OA pain,

Liposomal bupivacaine excreted in breast milk, but levels appear safe,

Tramadol mortality risk in osteoarthritis could outweigh benefits,